300+ investors in your industry, stage, and region Get
Any industry
Video Games
Hospitality
EdTech
Restaurants
Photography
Google
Construction
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Cryptocurrency
Oil and Gas
Film
Retail
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Software
Biotechnology
Renewable Energy
Crowdfunding
Recruiting
Venture Capital
Web3
Medical
Theatre
Social
Climate
LGBT
Cannabis
Celebrity
Life Science
Food and Beverage
Publishing
Infrastructure
Mobile Apps
Wine and Spirits
Music
Art
Real Estate
Sporting Goods
Manufacturing
Beauty
FinTech
Finance
Digital Media
Social Media
Financial Services
Franchise
Non Profit
Fashion
Internet
Mobile Advertising
Android
Proptech
Enterprise
Impact
Sustainability
Hardware
Biotech
Transportation
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Singapore
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Brazil
LATAM
Oman
Poland
Puerto Rico
Armenia
Cameroon
Guernsey
Colombia
China
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Moldova
Seychelles
Paraguay
Botswana
Canada
South Africa
France
Denmark
Georgia
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
India
Germany
Ireland
United States
Indonesia
Middle East
Dominican Republic
Asia
Bermuda
Albania
Spain
Europe
Argentina
Qatar
Angola
Cyprus
Barbados
Belgium
Jordan
Ethiopia
Austria
Azerbaijan
Bulgaria
Ecuador
Faroe Islands
Jersey
Bahrain
Estonia
Bahamas
Bolivia
Belize
Algeria
Italy
Belarus
Finland
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Bangladesh
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Peter Ibbotson, Investor Relations Partner at Swisscom Ventures

Peter Ibbotson

Investor Relations Partner @ Swisscom Ventures

Geneva, Switzerland

Peter Ibbotson is a Series A investor at Swisscom Ventures in Geneva focused on Medical and Biotechnology. Peter Ibbotson is based out of Geneva, Geneva and is the Investor Relations Partner of Swisscom Ventures. Peter previously worked at Endeavour as a CFO. Peter Ibbotson attended the HEC Lausanne - The Faculty of Business and Economics of the University of Lausanne. Peter Ibbotson has been recognised as the Chartered Financial Analyst.

Total investments:
1
Last investment:
Lead investor:
0%

Last updated:

Industries Peter Ibbotson invests in

MedicalBiotechnologyHealth DiagnosticsArtificial Intelligence

Stages Peter Ibbotson invests in

Series A

Countries Peter Ibbotson invests in

Switzerland

Contacts

TypeContactValidation
Work email
Personal email
Work phone
Personal phone
Socials

Sign up to unlock verified contacts

Unlock Contacts

Investment Focus

Industry

  • Medical 1 (100%)
  • Biotechnology 1 (100%)
  • Health Diagnostics 1 (100%)
  • Artificial Intelligence 1 (100%)

Investments

CompanyDescriptionRoundLinks
Scailyte has established a data-driven biomarker discovery platform that leverages unique expertise in single-cell data analysis and artificial intelligence. We are utilizing this platform to discover a new class of biomarkers, which are defined by the molecular profiles of disease-associated cells. This phenotypic approach to biomarker discoveryis radically new and directly related to the biology of a disease, which maximizes the success rate for discovering sensitive and robust biomarkers. $6.2M / Series A / Sep 19, 2022

Co-Investors

Swisscom Ventures

About Swisscom Ventures

VC Fund · Zürich, Switzerland

Swisscom Ventures is an venture capital arm of Swisscom AG, that specializes in early stage tech investments founded in 2007.Swisscom Ventures invests in growth companies with emerging business models and technologies of strategic relevance to Swisscom's core business. As a value-add investor, Swisscom brings its investees the technicalexpertise and strategic insights of an incumbent telecom operator. We act as a bridge to Swisscom's operational business units, which portfolio companies can also leverage as a test environment for their products and services.Swisscom Ventures seeks minority stakes in companies related to the information/communications/entertainment space.

Swisscom Ventures Contacts

NameEmailPhoneSocials
Alexander Schlaepfer
Alexander Schlaepfer Managing Partner
Carlo Grassi
Carlo Grassi CFO Swisscom Ventures
Peter Ibbotson
Peter Ibbotson Investor Relations Partner
Stefan Kuentz
Stefan Kuentz Investment Partner
Wanja Humanes
Wanja Humanes Investment Manager

Sign up to unlock verified contacts

Unlock Contacts

See all 9 contacts →

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Video Games
Hospitality
EdTech
Restaurants
Photography
Google
Construction
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Cryptocurrency
Oil and Gas
Film
Retail
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Software
Biotechnology
Renewable Energy
Crowdfunding
Recruiting
Venture Capital
Web3
Medical
Theatre
Social
Climate
LGBT
Cannabis
Celebrity
Life Science
Food and Beverage
Publishing
Infrastructure
Mobile Apps
Wine and Spirits
Music
Art
Real Estate
Sporting Goods
Manufacturing
Beauty
FinTech
Finance
Digital Media
Social Media
Financial Services
Franchise
Non Profit
Fashion
Internet
Mobile Advertising
Android
Proptech
Enterprise
Impact
Sustainability
Hardware
Biotech
Transportation
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Singapore
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Brazil
LATAM
Oman
Poland
Puerto Rico
Armenia
Cameroon
Guernsey
Colombia
China
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Moldova
Seychelles
Paraguay
Botswana
Canada
South Africa
France
Denmark
Georgia
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
India
Germany
Ireland
United States
Indonesia
Middle East
Dominican Republic
Asia
Bermuda
Albania
Spain
Europe
Argentina
Qatar
Angola
Cyprus
Barbados
Belgium
Jordan
Ethiopia
Austria
Azerbaijan
Bulgaria
Ecuador
Faroe Islands
Jersey
Bahrain
Estonia
Bahamas
Bolivia
Belize
Algeria
Italy
Belarus
Finland
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Bangladesh
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Peter Ibbotson invest in?

Peter Ibbotson invests primarily in Medical, Biotechnology and Health Diagnostics startups, most often at Series A stage. Most of the 1 investments tracked by Shizune back companies in Switzerland. The Investment Focus section breaks down every industry, stage and country in the portfolio.

How do I contact Peter Ibbotson?

Public channels for Peter Ibbotson include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

When did Peter Ibbotson last invest?

The most recent investment recorded for Peter Ibbotson closed in Sep 2022. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Peter Ibbotson Peter Ibbotson Find email